Costs associated with Alzheimer's disease in Italy: baseline results from the GERAS II observational study

被引:0
|
作者
Bruti, G. [1 ]
Bruno, G. [2 ]
Mancini, M. [1 ]
Reed, C. [3 ]
机构
[1] Eli Lilly Italy, Global Patient Safety Neurosci, Florence, Italy
[2] Univ Rome, Dept Neurol & Psychiat, Rome, Italy
[3] Eli Lilly & Co Ltd, Global Patient Outcomes & Real World Evidence, Windlesham, Surrey, England
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S61 / S62
页数:2
相关论文
共 50 条
  • [21] Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study
    Robinson, Rebecca L.
    Rentz, Dorene M.
    Bruemmer, Valerie
    Andrews, Jeffrey Scott
    Zagar, Anthony
    Kim, Yongin
    Schwartz, Ronald L.
    Ye, Wenyu
    Fillit, Howard M.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (01) : 279 - 292
  • [22] HOW TO DEAL WITH MISSING LONGITUDINAL DATA IN COST OF ILLNESS MODELS IN ALZHEIMER'S DISEASE - SUGGESTIONS FROM THE GERAS STUDY RESULTS
    Belger, M.
    Haro, J. M.
    Reed, C.
    Happich, M.
    Kahle-Wrobleski, K.
    Wimo, A.
    VALUE IN HEALTH, 2014, 17 (03) : A185 - A185
  • [23] Real-world Alzheimer's disease drug treatment-18-month results from an observational study in three European countries (GERAS; encore from 2016 EAN)
    Ueda, K.
    Reed, C.
    Lebrec, J.
    Dell'Agnello, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1026 - 1026
  • [24] Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study
    Reed, Catherine
    Belger, Mark
    Dell'Agnello, Grazia
    Wimo, Anders
    Argimon, Josep Maria
    Bruno, Giuseppe
    Dodel, Richard
    Haro, Josep Maria
    Jones, Roy W.
    Vellas, Bruno
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2014, 4 (01): : 51 - 64
  • [25] Costs study in Alzheimer's disease
    Martínez, JCA
    Izquierdo, AY
    Gardel, BEG
    REVISTA CLINICA ESPANOLA, 2004, 204 (02): : 64 - 69
  • [26] Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study
    Henneges, Carsten
    Reed, Catherine
    Chen, Yun-Fei
    Dell'Agnello, Grazia
    Lebrec, Jeremie
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 (03) : 1065 - 1080
  • [27] What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study
    Reed, Catherine
    Happich, Michael
    Maria Argimon, Josep
    Maria Haro, Josep
    Wimo, Anders
    Bruno, Giuseppe
    Dodel, Richard
    Jones, Roy W.
    Vellas, Bruno
    Belger, Mark
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (03) : 797 - 812
  • [28] PREDICTORS OF DISEASE PROGRESSION IN MILD ALZHEIMER'S DISEASE DEMENTIA PATIENTS - RESULTS FROM THE GERAS REAL WORLD COHORT AND EXPEDITION TRIALS
    Reed, C.
    Lebrec, J.
    Andrews, J. S.
    Bruno, G.
    Jones, R. W.
    VALUE IN HEALTH, 2016, 19 (07) : A425 - A426
  • [29] Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study
    Alan Lenox-Smith
    Catherine Reed
    Jeremie Lebrec
    Mark Belger
    Roy W. Jones
    BMC Geriatrics, 18
  • [30] Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study
    Li, Fangyu
    Chen, Shuoqi
    Wei, Cuibai
    Jia, Jianping
    BMC NEUROLOGY, 2017, 17